2 results match your criteria: "Chief Carlo Forlanini Hospital[Affiliation]"
Bisphosphonate use in patients with lung cancer and bone metastases: recommendations of a European expert panel.
J Thorac Oncol
October 2009
Thoracic Oncology Unit I, Chief Carlo Forlanini Hospital, Rome, Italy.
Article Synopsis
- Bisphosphonates (BPs) are medicines that help patients with lung cancer who have bones affected by the disease, making it less likely for them to have problems with their bones.
- A group of doctors got together to review how effective BPs are and to make recommendations for treating lung cancer patients with bone issues.
- The doctors suggest that all lung cancer patients should be checked for bone problems when they first get diagnosed, and if they have bone metastases, they should use BPs to help manage the disease and pain.
Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer.
Oncologist
April 2008
Thoracic Oncology Unit I, Chief Carlo Forlanini Hospital, Pza Forlanini 1, 00151, Rome, Italy.
In the U.S. and Europe, the current options for the second- and third-line treatment of advanced non-small cell lung cancer (NSCLC) are cytotoxic drugs and targeted agents.
View Article and Find Full Text PDF